Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|January 11, 2007
The adverse effects of hallucinogens from intramural perspectiveEde Frecska, Luis Eduardo LunaConvulsive Therapy|January 1, 1989
Prolactin Response to Pentylenetetrazol (Cardiazol) Convulsive TherapyMihály Arató, Ede Frecska, Gyöngyi SoltiFrontiers in Pharmacology|March 15, 2016
The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of CivilizationEde Frecska, Petra Bokor, Michael WinkelmanInternational Review of Neurobiology|June 20, 2025
The protective effect of DMT against neurodegenerationEde Frecska, Attila Kovács, Attila SzaboPsychiatry Research|June 12, 2003
Blunted prolactin response to fentanyl in depression. Normalizing effect of partial sleep deprivationEde Frecska, Andras Perenyi, Mihaly AratoNeuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|April 14, 2005
[Misdiagnosed PTSD and zeldox pharmacotherapy in case of a political prisoner]Ede Frecska, Mária Keresztes, Gábor GasznerEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 14, 2023
The potential of psychedelics for the treatment of Alzheimer's disease and related dementiasMichael James Winkelman, Attila Szabo, Ede FrecskaNeuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|July 9, 2016
[The potential use of ayahuasca in psychiatry]Ede Frecska, Petra Bokor, Gabor Andrassy, et al.Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|October 21, 2015
[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca]Attila Szabó, Anita Kazai, Ede Frecska, et al.Current Neuropharmacology|May 31, 2017
The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative DiseasesBotond Penke, Livia Fulop, Maria Szucs, et al.Pageof 6